throbber
No. 21-1272
`
`
`
`In The
`Supreme Court of the United States
`___________
`
`MONSANTO COMPANY,
`
`Petitioner,
`
`
`v.
`
`
`ALBERTA PILLIOD AND ALVA PILLIOD,
`
`Respondents.
`___________
`
`On Petition for a Writ of Certiorari to the
`Court of Appeal of California
`___________
`
`BRIEF OF WASHINGTON LEGAL FOUNDATION
`AND ALLIED EDUCATIONAL FOUNDATION AS
`AMICI CURIAE SUPPORTING PETITIONER
`___________
`
`
`
`
`
`
`
`John M. Masslon II
` Counsel of Record
`Cory L. Andrews
`WASHINGTON LEGAL FOUNDATION
`2009 Massachusetts Ave. NW
`Washington, DC 20036
`(202) 588-0302
`jmasslon@wlf.org
`
`
`April 19, 2022
`
`
`
`

`

`QUESTIONS PRESENTED
`
`1. Whether the Federal Insecticide, Fungicide,
`
`and Rodenticide Act preempts state-law failure-to-
`warn claims where the warning cannot be added to a
`product without Environmental Protection Agency
`approval and EPA has repeatedly rejected the
`warning.
`
`2. Whether a punitive-damages award that is
`
`four times a substantial compensatory-damages
`award violates the Fourteenth Amendment’s Due
`Process Clause when the defendant acted reasonably.
`
`

`

`
`
`
`
`
`iii
`
`TABLE OF CONTENTS
`
`Page
`
`QUESTIONS PRESENTED .................................... i
`
`TABLE OF AUTHORITIES .................................. iv
`
`INTERESTS OF AMICI CURIAE .......................... 1
`
`INTRODUCTION ................................................... 2
`
`STATEMENT .......................................................... 3
`
`SUMMARY OF ARGUMENT ................................. 5
`
`ARGUMENT ........................................................... 7
`
`I. WHETHER STATE-LAW FAILURE-TO-WARN
`CLAIMS OVER GLYPHOSATE ARE PREEMPTED
`BY FIFRA IS AN ISSUE OF NATIONAL
`IMPORTANCE ...................................................... 7
`
`A. The Process For Listing Glyphosate
`As Dangerous To Humans Was
`Unscientific Rent Seeking ..................... 7
`
`B. Companies Will Not Invest In
`Pesticides If They Will Face Liability
`For Complying With Federal Law ....... 12
`
`II. THIS CASE COULD RESOLVE UNCERTAINTY
`ABOUT IMPLIED PREEMPTION IN OTHER
`AREAS .............................................................. 14
`
`III. REVIEW IS NEEDED TO CLARIFY THE LIMITS
`ON PUNITIVE-DAMAGES AWARDS ..................... 15
`
`CONCLUSION ...................................................... 19
`
`

`

`
`
`
`
`
`iv
`
`TABLE OF AUTHORITIES
`
` Page(s)
`
`Cases
`
`A.Y. v. Janssen Pharms. Inc.,
`224 A.3d 1 (Pa. Super. 2019) ........................... 15
`
`Bach v. First Union Nat. Bank,
`486 F.3d 150 (6th Cir. 2007) ............................ 16
`
`Bates v. Dow Agrosciences LLC,
`544 U.S. 431 (2005) ............................................ 4
`
`BMW of N. Am., Inc. v. Gore,
`517 U.S. 559 (1996) .......................................... 15
`
`Bristol-Myers Squibb Co. v. Superior
`Ct. of Cal., S.F. Cnty.,
`137 S. Ct. 1773 (2017) ........................................ 7
`
`Byrd v. Janssen Pharm., Inc.,
`333 F. Supp. 3d 111 (N.D.N.Y. 2018) ........ 14, 15
`
`Cote v. Philip Morris USA, Inc.,
`985 F.3d 840 (11th Cir. 2021) .......................... 16
`
`DIRECTV, Inc. v. Imburgia,
`577 U.S. 47 (2015) .............................................. 7
`
`Exxon Shipping Co. v. Baker,
`554 U.S. 471 (2008) .................................... 17, 18
`
`Honda Motor Co. v. Oberg,
`512 U.S. 415 (1994) .......................................... 15
`
`Jones v. United Parcel Serv., Inc.,
`674 F.3d 1187 (10th Cir. 2012) ........................ 16
`
`Merck Sharp & Dohme
`Corp. v. Albrecht,
`139 S. Ct. 1668 (2019) ...................................... 14
`
`

`

`
`
`
`
`
`
`
` v
`
`TABLE OF AUTHORITIES
`(continued)
`
` Page(s)
`
`Monsanto Co. v. Off. of Env’t
`Health Hazard Assessment,
`22 Cal. App. 5th 534 (2018) ............................... 1
`
`PLIVA, Inc. v. Mensing,
`564 U.S. 604 (2011) .......................................... 14
`
`Saccameno v. U.S. Bank Nat’l Ass’n,
`943 F.3d 1071 (7th Cir. 2019) .......................... 16
`
`State Farm Mut. Auto.
`Ins. Co. v. Campbell,
`538 U.S. 408 (2003) .............................. 15, 16, 17
`
`Wyeth v. Levine,
`555 U.S. 555 (2009) .......................................... 14
`
`Constitutional Provision
`
`U.S. Const. art. VI, § 2 ............................................ 7
`
`Statutes
`
`7 U.S.C.
`§136a(a) .............................................................. 4
`§136a(c) .............................................................. 4
`§ 136a(c)(1) ......................................................... 4
`§ 136j(a)(1)(B)..................................................... 4
`
`Cal. Health & Saf. Code § 25249.6 ......................... 3
`
`Cal. Health & Saf. Code § 25249.8(a) ..................... 3
`
`Cal. Labor Code § 6382(b)(1) .................................. 3
`
`

`

`
`
`
`
`
`vi
`
`TABLE OF AUTHORITIES
`(continued)
`
` Page(s)
`
`Regulations
`
`21 C.F.R.
`§ 201.57(a)(6) .................................................... 15
`§ 201.57(a)(7) .................................................... 15
`§ 201.57(a)(10) .................................................. 15
`§ 201.57(a)(11) .................................................. 15
`§ 201.57(c)(2)(ii) ............................................... 15
`
`40 C.F.R.
`§ 156.10(a)(1)(vii) ............................................... 4
`§ 156.60 .............................................................. 4
`§ 158.500 ............................................................ 4
`
`Other Authorities
`
`Ben Webster, Weedkiller Scientist Was
`Paid £120,000 by Cancer Lawyers,
`Times of London (Oct. 18, 2017) ...................... 10
`
`Claire C. Weglarz, Unsound Expansion
`of Strict Liability Failure to Warn in
`California: Johnson v. Monsanto
`Co., WLF LEGAL OPINION LETTER
`(July 9, 2021)...................................................... 1
`
`EPA, Glyphosate .................................................. 8, 9
`
`Improved Management of Herbicides in
`Conservation Agriculture Systems
`Using Nuclear Techniques, Int’l
`Atomic Energy Agency .................................... 13
`
`Jill Wieber Lens, Procedural Due
`Process and Predictable Punitive
`Damage Awards,
`2012 B.Y.U. L. Rev. 1 (2012) ........................... 17
`
`

`

`
`
`
`
`
`vii
`
`TABLE OF AUTHORITIES
`(continued)
`
` Page(s)
`
`Kate Kelland, Cancer Agency Left in the
`Dark over Glyphosate Evidence,
`Reuters (June 14, 2017) ................................... 11
`
`Laura J. Hines & N. William Hines,
`Constitutional Constraints on
`Punitive Damages: Clarity,
`Consistency, and the
`Outlier Dilemma,
`66 Hastings L.J. 1257 (2015) ........................... 17
`
`Pesticides and food safety, Government
`of Canada (Jan. 18, 2021) ................................ 13
`
`Victor E. Schwartz & Christopher E.
`Appel, Roundup Cases May Be a
`New Example of an Old Problem:
`The Post Hoc Fallacy, WLF LEGAL
`BACKGROUNDER (Aug. 9, 2019) .......................... 1
`
`
`
`

`

`
`
`
`
`
`
`
` 1
`
`INTERESTS OF AMICI CURIAE*
`
`Washington Legal Foundation is a nonprofit,
`public-interest law firm and policy center with
`supporters nationwide. WLF
`promotes
`free
`enterprise, individual rights, limited government,
`and the rule of law. It often appears as amicus curiae
`in cases about California’s Proposition 65. See, e.g.,
`Nat’l Assoc. of Wheat Growers v. Bonta, No. 20-16758
`(9th Cir. brief filed May 19, 2021); Monsanto Co. v.
`Off. of Env’t Health Hazard Assessment, 22 Cal. App.
`5th 534 (2018).
`
`WLF’s Legal Studies Division also regularly
`publishes pieces by outside experts on glyphosate.
`See, e.g., Claire C. Weglarz, Unsound Expansion of
`Strict Liability Failure to Warn in California:
`Johnson v. Monsanto Co., WLF LEGAL OPINION
`LETTER (July 9, 2021); Victor E. Schwartz &
`Christopher E. Appel, Roundup Cases May Be a New
`Example of an Old Problem: The Post Hoc Fallacy,
`WLF LEGAL BACKGROUNDER (Aug. 9, 2019).
`
`Allied Educational Foundation is a nonprofit
`charitable and educational foundation based in
`Tenafly, New Jersey. Founded in 1964, AEF promotes
`education in diverse areas of study, including law and
`public policy. It has appeared as amicus often in this
`Court.
`
`
`
`* No party’s counsel authored any part of this brief. No
`person or entity, other than amici and their counsel, paid for the
`brief’s preparation or submission. After timely notice, all parties
`consented to amici’s filing this brief.
`
`
`
`

`

`
`
`
`
`
`
`
` 2
`
`INTRODUCTION
`
`Recently, the United Kingdom of Great Britain
`and Northern Ireland withdrew from the European
`Union. Brexit was controversial both in England and
`abroad. But after a nationwide referendum and
`multiple general elections, the British people spoke
`loudly in support of leaving the EU.
`
`The rallying cry behind Brexit was a feeling
`that Britain was no longer making key policy
`decisions for its citizens. Rather than resulting from
`the British Parliament’s own deliberations, decisions
`affecting Brits were being made by Brussels. And the
`European Parliament made decisions binding Britain
`using European analysis based on European
`interests.
`
`This case presents a similar issue. Americans’
`elected representatives gave the Environmental
`Protection Agency authority over pesticides. EPA
`makes decisions based on its well-funded research
`that focuses on what is best for Americans. This, of
`course, is a regulation of commerce between the
`several States and foreign nations.
`
`Under the Supremacy Clause, the States
`cannot overrule this federal policy decision. But that
`has never stopped California from passing laws that
`are both expressly and conflict preempted by federal
`law. California enacted Proposition 65 and allowed
`others around the world to decide what poses a risk to
`Americans. Activists exploited this legislation to
`achieve their policy goals using civil litigation.
`
`
`

`

`
`
`
`
`
`
`
` 3
`
` Realizing that any researcher following the
`scientific method would find glyphosate poses no risk
`to humans, activists built in multiple backup plans. A
`substance is covered by Prop 65 if only one of a
`smorgasbord of alphabet-soup agencies finds it
`potentially harmful to humans.
`
`in
`This has caused dire consequences
`California. Companies are placed in the impossible
`position of either ignoring federal law or facing
`massive liability for not following California law.
`After massive judgments in these cases, California
`piles on more by allowing juries to impose outsized
`punitive damages awards that violate the Fourteenth
`Amendment’s Due Process Clause. Enough is enough.
`This Court’s intervention is necessary, yet again, to
`remind California that it too is bound by federal law.
`
`
`STATEMENT
`
`
`Adopted by California voters in 1986, Prop 65
`provides that “[n]o person in the course of doing
`business shall knowingly and intentionally expose
`any individual to a chemical known to the state to
`cause cancer * * * without first giving clear and
`reasonable warning to such individual.” Cal. Health
`& Saf. Code § 25249.6. The State publishes a list of
`chemicals “known to the state” to cause cancer. Id.
`§ 25249.8(a). That list must include any substance
`identified as a potential carcinogen in experimental
`animals by the International Agency for Research on
`Cancer. See Cal. Labor Code § 6382(b)(1); Cal. Health
`& Saf. Code § 25249.8(a). All products including a
`detectable amount of one of the listed chemicals must
`include the warning. See Cal. Health & Saf. Code
`§ 25249.6.
`
`

`

`
`
`
`
`
`
`
` 4
`
`But state law is not the final word on labeling
`pesticides. Under the Federal Insecticide, Fungicide,
`and Rodenticide Act, companies must register a
`pesticide before selling it in the United States. 7
`U.S.C. § 136a(a). The registration must include
`proposed labeling with any health warnings. E.g., id.
`§ 136a(c); 40 C.F.R. §§ 156.10(a)(1)(vii), 156.60,
`158.500. After EPA approves a label, it may not be
`altered without EPA approval. See Bates v. Dow
`Agrosciences LLC, 544 U.S. 431, 438 (2005); 7 U.S.C.
`§§ 136a(c)(1), 136j(a)(1)(B). This means that a
`company cannot include a Prop 65 warning on a
`pesticide without EPA approval.
`
`From the early 1980s until the early 2010s,
`Respondents used Roundup on their property. After
`being diagnosed with non-Hodgkin’s lymphoma, they
`sued Monsanto claiming that Roundup caused their
`non-Hodgkin’s
`lymphoma because
`it
`contains
`glyphosate.
`
`After the Superior Court refused to recognize
`that federal law preempted Respondents’ claims, the
`case went to trial. A jury awarded them over $54
`million in compensatory damages and $2 billion in
`punitive damages. The trial court reduced that
`amount to about $18 million in compensatory
`damages and $69 million in punitive damages.
`
`Monsanto appealed to the California Court of
`Appeal. As it has repeatedly done, that court held that
`federal law cannot preempt California’s labeling
`requirements. Pet. App. 30a. In its view, FIFRA
`cannot impliedly preempt a state law. See id. Then,
`ignoring the decisions of several federal courts of
`appeals,
`the court held
`that a punitive
`to
`
`

`

`
`
`
`
`
`
`
` 5
`
`compensatory damages ratio of 4:1 is permissible—
`even when compensatory damages are significant.
`Pet. App. 80a, 82a. Because the Supreme Court of
`California abdicated its responsibility to ensure that
`federal law is properly applied in the State, Pet. App.
`1a, Monsanto seeks certiorari.
`
`
`SUMMARY OF ARGUMENT
`
`
`I.A. Congress gave EPA the power to regulate
`pesticide labels and to decide what warnings are
`scientifically
`appropriate. EPA’s
`analysis
`of
`glyphosate shows that it poses no risk to humans.
`Unsurprisingly, every other reputable agency in the
`world to investigate the question has reached the
`same conclusion.
`
`The plaintiffs’ bar, however, found a loophole in
`Prop 65. Rather than allow the scientific agencies to
`review data unbiasedly, it got two moles onto one
`overseas agency. Relying on the same data that other
`groups—including California regulators—used to find
`no risk, the agency found that glyphosate may cause
`cancer in humans. So the warning that California
`requires is based on rent seeking—not science.
`
`B. Companies will face an impossible decision
`if the Court of Appeal’s decision stands. They must
`either follow federal law and subject themselves to
`billions of dollars in damages or add a warning and
`break federal law. Companies will act rationally and
`stop making pesticides and stop innovating. This will
`decrease food security both in the United States and
`abroad. In other words, people could starve if the
`decision remains.
`
`
`

`

`
`
`
`
`
`
`
` 6
`
`II. State courts have recently abandoned this
`Court’s preemption
`jurisprudence. Rather than
`looking at whether the
`federal statutory and
`regulatory scheme impliedly preempt state laws,
`these state courts have held that States can impose
`any labeling requirements they want. This case gives
`the Court the chance to correct those errors and send
`a strong message about proper application of its
`preemption jurisprudence.
`
`III. This Court should also grant review to
`resolve a split among lower courts on how to apply its
`due-process precedents. The Court has said that when
`there
`is a substantial award of compensatory
`damages, the Due Process Clause may limit a
`punitive damages award to the amount of the
`compensatory award. Many courts have properly
`heeded this guidance. But the California Court of
`Appeal did not do so here.
`
`Capping the ratio of punitive damages to
`substantial compensatory damages at 1:1 ensures
`that parties know their risk of exposure. Rather than
`having to guess at potential punitive damages,
`companies would know that, when a damages award
`is substantial, they may be forced to pay only the
`same amount in punitive damages. This ensures
`compliance with the Due Process Clause.
`
`
`

`

`
`
`
`
`
`
`
` 7
`
`I.
`
`
`
`
`ARGUMENT
`
`WHETHER STATE-LAW FAILURE-TO-WARN
`CLAIMS OVER GLYPHOSATE ARE PREEMPTED
`BY FIFRA IS AN ISSUE OF NATIONAL
`IMPORTANCE.
`
`The Constitution provides that when state law
`conflicts with federal law, federal law prevails. See
`U.S. Const. art. VI, § 2. But the California courts treat
`this command as a mere suggestion. This Court often
`must reverse decisions from California because its
`courts allow state law to trump federal law. E.g.,
`Bristol-Myers Squibb Co. v. Superior Ct. of Cal., S.F.
`Cnty., 137 S. Ct. 1773 (2017); DIRECTV, Inc. v.
`Imburgia, 577 U.S. 47 (2015). The Court should once
`again step in and remind California that it too must
`play by the rules.
`
`A.
`
`The Process For Listing Glyphosate
`As Dangerous To Humans Was
`Unscientific Rent Seeking.
`
`
`One reason that Congress gave EPA the power
`to regulate pesticide labels is because of the agency’s
`scientific expertise. Rather than leave it up to state
`agencies, Congress found it necessary to nationalize
`the label-approval process. Yet under the Court of
`Appeal’s decision, each State can make its own
`decisions about pesticides. Even if that decision is
`based on zero scientific evidence, companies like
`Monsanto must
`comply with
`the
`labeling
`requirements. Allowing such state-level decisions
`eviscerates Congress’s policy goal of national
`uniformity for pesticide labeling.
`
`
`

`

`
`
`
`
`
`
`
` 8
`
`1. IARC’s working group’s decision that
`glyphosate is a carcinogen is an outlier. No other
`scientific agency has reached the same conclusion. In
`fact, they all have reached the opposite conclusion;
`glyphosate poses no risk to humans. In 1997 and
`2007, the California Office of Environmental Health
`and Hazard Assessment determined that glyphosate
`is unlikely to pose a cancer hazard to humans. See
`Am. Pet., ¶ 35, Monsanto Co. v. Cal. Citrus Mut., 2017
`WL 3784249 (Cal. Super. Mar. 20, 2017) (No. 16-CE-
`CG-00183). These determinations were made after
`reviewing the same dataset that led the IARC to reach
`the opposite conclusion. Id. ¶ 36.
`
`So a California regulatory body found that
`glyphosate poses no risk to humans. But under Prop
`65, this determination means nothing if activists can
`persuade another agency to reach the opposite
`conclusion. Here, activists asked many agencies to
`find that glyphosate causes cancer. Most reached the
`same result that the California did. The German
`Federal Institute for Risk Assessment, European
`Food Safety Authority, Canadian Pest Management
`Regulatory
`Authority,
`and World Health
`Organization all have found no evidence that
`glyphosate harms humans. See Am. Pet., supra ¶¶ 37-
`48.
`
`is EPA’s
`importantly, however,
`Most
`conclusions about glyphosate. EPA found that there
`are “[n]o risks of concern to human health from
`current uses of glyphosate.” EPA, Glyphosate,
`https://bit.ly/38xdm3Q (last visited Apr. 18, 2022). If
`products like Roundup are “used according to label
`directions,” they “do not result in risks to children or
`adults.” Id.
`
`

`

`
`
`
`
`
`
`
` 9
`
`There is similarly “[no] indication that children
`are more sensitive to glyphosate.” EPA, supra. EPA
`reviewed “numerous studies from [many] sources”
`and “found no indication that children are more
`sensitive to glyphosate from in utero or post-natal
`exposure.” Id.
`
`After “undergo[ing] Tier I screening under
`EPA’s Endocrine Disruptor Screening Program,” EPA
`found “[n]o indication that glyphosate is an endocrine
`disruptor.” EPA, supra. In other words, “data do not
`indicate that glyphosate has the potential to interact
`with the estrogen, androgen or thyroid signaling
`path.” Id.
`
`More to the point, EPA found “[n]o evidence
`that glyphosate causes cancer in humans.” EPA,
`supra. When reaching this decision, it “considered a
`significantly more extensive and relevant dataset
`than” IARC. Id. EPA examined “studies submitted to
`support registration of glyphosate and studies EPA
`identified in the open literature.” Id.
`
`consistent with other
`“is
`finding
`This
`international
`expert
`panels
`and
`regulatory
`authorities.” EPA, supra. Along with those agencies
`listed above, others that have found glyphosate poses
`no risk to humans include the “New Zealand
`Environmental Protection Authority[] and the Food
`Safety Commission of Japan.” Id.
`
`2. Despite
`this overwhelming scientific
`evidence that glyphosate poses no risk to humans,
`IARC found that it is a carcinogen. How could such a
`supposedly expert agency veer so far off course? The
`answer is simple, unethical rent seeking.
`
`

`

`
`
`
`
`
`10
`
`Christopher Portier played a leading role in
`IARC’s evaluation of glyphosate despite a severe
`financial conflict of interest. Before joining IARC,
`Portier was affiliated with the Environmental
`Defense Fund, which litigates against all use of
`pesticides. Although lacking any glyphosate expertise
`or experience, Portier chaired the IARC committee
`that proposed glyphosate as a substance to be studied
`by an IARC working group. He then served as a
`specialist and advisor to that working group.
`
`Portier did not disclose his financial ties to law
`firms that sued Monsanto for glyphosate’s alleged
`carcinogenicity. The same week that IARC listed
`glyphosate as a probable human carcinogen, Portier
`signed a lucrative consulting contract with two law
`firms, under which he assisted the firms with their
`glyphosate
`litigation. Portier soon made over
`$160,000. See Ben Webster, Weedkiller Scientist Was
`Paid £120,000 by Cancer Lawyers, Times of London
`(Oct. 18, 2017), https://bit.ly/3DJRXQv. Portier
`admitted that he had been hired by one of the law
`firms at least two months before the IARC issued its
`glyphosate determination. Id.
`
`Portier’s unethical rent seeking did not stop
`there. Later, he lobbied extensively for acceptance of
`the IARC’s determination by governmental bodies
`and for rejecting contrary findings by other scientific
`groups. When Portier engaged in such activities,
`however, he neglected to mention that he was on the
`plaintiffs’ bar’s payroll.
`
`Similarly troubling is the conduct of retired
`epidemiologist Aaron Blair, who led IARC’s review of
`glyphosate. Blair was aware of significant scientific
`
`

`

`
`
`
`
`
`11
`
`evidence showing that glyphosate is not a human
`carcinogen, yet he did not bring that evidence to the
`IARC working group’s attention. Kate Kelland,
`Cancer Agency Left in the Dark over Glyphosate
`Evidence, Reuters
`(June 14, 2017), https://
`reut.rs/370z8wf.
`
`One of the largest and best surveys of the
`effects of pesticide use on humans is the Agricultural
`Health Study, a study of about 89,000 American
`agricultural workers that has been gathering detailed
`health information for 25 years. Blair played a key
`role in a research study based on AHS data. In 2013,
`the researchers issued a draft report that concluded
`that glyphosate was not a human carcinogen. Yet
`when the final study was published, it omitted any
`discussion of glyphosate.
`
`Blair said that the glyphosate material was
`deleted from the published study “because there was
`too much to fit into one scientific paper.” Kelland,
`supra. But independent scientists who reviewed the
`draft study found no legitimate reason to exclude the
`glyphosate findings. Id. Blair conceded that the
`material exonerated glyphosate and would have
`affected IARC’s final determination had it been
`presented. Id. The material was never considered by
`the IARC working group, however, because Blair hid
`it. This suggests that Blair deliberately concealed his
`research findings—not the type of conduct one would
`expect from a scientist supervising a purportedly
`unbiased study of glyphosate.
`
`that
`shows
`scientific evidence
`the
`So
`glyphosate is not a carcinogen. Every reputable
`scientific body to examine the issue, including
`
`

`

`
`
`
`
`
`12
`
`California’s regulator and EPA, reached this result.
`The only contrary finding comes from a group that
`was
`infiltrated by the plaintiffs’ bar’s moles.
`Requiring a glyphosate warning thus undermines
`Congress’s goal of ensuring that pesticide labels
`present only
`information that
`is scientifically
`accurate. This causes consumers to pay less attention
`to the warnings on pesticide labels backed by rigorous
`scientific inquiry.
`
`B.
`
`Companies Will Not Invest In
`Pesticides
`If They Will Face
`Liability For Complying With
`Federal Law.
`
`
`If this Court declines to hear this appeal,
`immense consequences will follow. One of the main
`reasons that companies are willing to devote limited
`resources to developing and distributing pesticides is
`that they are protected from frivolous state-law
`claims. They understand that, under FIFRA and this
`Court’s precedent, state-law claims for adhering to
`EPA regulations are preempted by federal law. But if
`the Court of Appeal’s decision stands, this assurance
`will vanish. Companies will have to face the
`impossible choice of either complying with federal law
`or risking billions of dollars in state-law damages.
`
`When faced with potential liability that dwarfs
`possible profits, the companies may decide that the
`risks outweigh the rewards. This means companies
`will produce fewer effective pesticides. And fewer
`effective pesticides means less, and more expensive,
`food.
`
`
`
`

`

`
`
`
`
`
`13
`
`“Pesticides play an important role in making
`sure there is enough food for everyone, by protecting
`crops from pests like insects, weeds, and fungal
`diseases.” Pesticides and food safety, Government of
`Canada (Jan. 18, 2021), https://bit.ly/3uhVOkq; see
`Improved Management of Herbicides in Conservation
`Agriculture Systems Using Nuclear Techniques, Int’l
`Atomic Energy Agency, https://bit.ly/3JfL3n3 (last
`visited Apr. 18, 2022) (“The use of herbicides is one of
`the potential
`factors
`that make agricultural
`intensification economically viable, hence improve
`food security.”). Glyphosate is one of the three most
`popular pesticides. See id.
`
`If companies must stop innovating and cannot
`use glyphosate for fear of failure-to-warn liability,
`farmers will have to use less-effective pesticides. That
`will lead to lower food yields. Then the laws of supply
`and demand will take over and food prices will rise.
`The poorest among us will be unable to put food on
`the table or will have to choose between medicine and
`food.
`
`
`Although this may appear to be a one-off
`decision, the lynchpin to our nation’s pesticide
`industry is the predictability of federal law. If a single
`state court can go off the rails and impose billions of
`dollars in costs, then companies must factor that into
`their cost-benefit analysis. Many may decide that the
`intolerable risk is not worth taking.
`
`So the legal problems with the Court of
`Appeal’s decision is not the only reason to grant
`review here. This case affects the wider pesticide
`industry. Blessing—through silence—the Court of
`Appeal’s opinion will discourage innovation. This
`
`

`

`
`
`
`
`
`14
`
`II.
`
`
`
`Court should not take that risk. Rather, it should hear
`this case and reaffirm the supremacy of federal law.
`
`THIS CASE COULD RESOLVE UNCERTAINTY
`ABOUT IMPLIED PREEMPTION IN OTHER
`AREAS.
`
`This case would clarify the scope of implied
`preemption under FIFRA. But it would also help
`clarify implied preemption in other areas too. State
`courts continue to incorrectly hold that federal laws
`do not impliedly preempt state laws about labeling—
`even when it is impossible to comply with both
`regulatory schemes. This case presents the Court
`with the opportunity to fix the problem.
`
`The Court of Appeal tried to distinguish this
`case from those under the Food, Drug, and Cosmetic
`Act. See Pet. App. 29a-30a. But as described in the
`Petition (at 16-17), the preemption analysis under
`FIFRA is virtually the same as that under the FDCA.
`So it comes as no surprise that a split is also present
`among lower courts about the breadth of preemption
`for drug labels. A failure-to-warn claim is preempted
`by the FDCA if (1) the warning could not have been
`added without prior FDA approval, PLIVA, Inc. v.
`Mensing, 564 U.S. 604, 617-19 (2011), or (2) there is
`“clear evidence” that the FDA would not approve a
`warning required under state law. Merck Sharp &
`Dohme Corp. v. Albrecht, 139 S. Ct. 1668, 1672 (2019)
`(quoting Wyeth v. Levine, 555 U.S. 555, 571 (2009)).
`
`Some courts have properly applied the FDCA’s
`
`preemption claim by holding that, under the FDCA,
`drug companies cannot unilaterally change a drug’s
`label to warn of off-label uses. Byrd v. Janssen
`
`

`

`
`
`
`
`
`15
`
`Pharm., Inc., 333 F. Supp. 3d 111, 117, 120 (N.D.N.Y.
`2018); see 21 C.F.R. §§ 201.57(a)(6), (a)(7), (a)(10),
`(a)(11), (c)(2)(ii). But other courts have reached the
`opposite conclusion. In these courts’ views, state
`failure-to-warn claims for off-label use are not
`preempted by this statutory and regulatory structure.
`See, e.g., A.Y. v. Janssen Pharms. Inc., 224 A.3d 1, 17
`(Pa. Super. 2019).
`
`So this Court can clarify implied preemption
`under both FIFRA and the FDCA by granting the
`Petition. It should seize the day and give lower courts
`direction on how to apply the Court’s preemption
`precedent. The Court should not allow state courts to
`continue to ignore that precedent and permit failure-
`to-warn claims for labels regulated by federal
`agencies.
`
`
`III. REVIEW IS NEEDED TO CLARIFY THE LIMITS
`
`ON PUNITIVE-DAMAGES AWARDS.
`
`Many courts continue to ignore due-process
`limits on punitive damage awards, which were
`already “well established” two decades ago. State
`Farm Mut. Auto. Ins. Co. v. Campbell, 538 U.S. 408,
`416 (2003). Ignoring due-process principles deprives
`defendants of their right to “fair notice * * * of the
`severity of the penalty that a State may impose.”
`BMW of N. Am., Inc. v. Gore, 517 U.S. 559, 574 (1996)
`(citations omitted). This leads to an “arbitrary
`deprivation of property” by punitive damages bearing
`no relation to the plaintiffs’ injury. Honda Motor Co.
`v. Oberg, 512 U.S. 415, 432 (1994). The decision here
`is particularly egregious because it is based on junk
`science that EPA and almost every other scientific
`body in the world has rejected.
`
`

`

`
`
`
`
`
`16
`
`In State Farm, the Court said that “[w]hen
`compensatory damages are substantial,” a 1:1 ratio
`between
`compensatory damages and punitive
`damages may “reach the outermost limit of the due
`process guarantee.” 538 U.S. at 425. Some courts have
`disregarded this guidance as nonbinding “dicta.” E.g.,
`Cote v. Philip Morris USA, Inc., 985 F.3d 840, 849
`(11th Cir. 2021) (citation omitted). Other courts have
`taken this Court at its word and imposed a 1:1 limit
`on punitive damages when there is a substantial
`compensatory award. E.g., Saccameno v. U.S. Bank
`Nat’l Ass’n, 943 F.3d 1071, 1090 (7th Cir. 2019).
`
`Although the exact line of what is substantial
`is blurry, the judgment here meets any standard for a
`substantial award. For example, the Tenth Circuit
`has held that a $630,000 award is substantial. Jones
`v. United Parcel Serv., Inc., 674 F.3d 1187, 1208 (10th
`Cir. 2012). In the Sixth Circuit, $400,000 suffices.
`Bach v. First Union Nat. Bank, 486 F.3d 150, 156 (6th
`Cir. 2007). The judgment here is 27 times the size of
`a substantial award in the Tenth Circuit and 42 times
`the size of a substantial award in the Sixth Circuit.
`So it qualifies as substantial under any test.
`
`B. Despite the Court’s prior reluctance to
`specify “a bright-line ratio,” State Farm, 538 U.S. at
`425, the Court should impose a firm 1:1 cap on the
`ratio of punitive to compensatory damages when
`compensatory damages are substantial. Such a cap
`would ensure that punitive damages bear some
`reasonable relationship to the harm and stay within
`constitutional bounds.
`
`Developments after State Farm show why the
`Court should draw a bright-line ratio for punitive
`
`

`

`
`
`
`
`
`17
`
`damages to substantial compensatory damages.
`Despite hopes that State Farm would ensure
`defendants knew of their punitive-damage exposure,
`it
`did not
`“reduce
`the
`inconsistency
`or
`unpredictability of punitive damages awards.” Laura
`J. Hines & N. William Hines, Constitutional
`Constraints
`on Punitive Damages: Clarity,
`Consistency, and the Outlier Dilemma, 66 Hastings
`L.J. 1257, 1257 (2015).
`
`To solve the problem in maritime suits, the
`Court held that a 1:1 ratio was the maximum
`permissible punitive damages award after a $500
`million
`compensatory-damages
`award. Exxon
`Shipping Co. v. Baker, 554 U.S. 47

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket